HCPCS Code J9263: Injection, Oxaliplatin, 0.5 mg

Yes. But based on clinical trials/clinical studies, the National Comprehensive Cancer Network has given the disclaimer that you shouldn't use this drug if the patient has already taken FOLFOX or CAPEOX because adding more oxaliplatin can cause "serious nerve damage."

The common risks associated with this medicine include temporary loss of blood cell counts, nausea (with vomiting), diarrhea, and peripheral neuropathy. Adverse reactions include severe allergic reactions, kidney toxicity, liver toxicity, and injection site infections (this one can be avoided by applying an antiseptic before the infusion).

Radiation therapy, targeted therapy, immunotherapy, and other chemotherapy drugs.